Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gregory Kaufmann

Diagnostic Radiology Kendall Park, NJ Medical Doctor

NPI 1659391647 CMS profile 552539

3674 Route 27, Princeton Radiology Associates, P.A., Department B, Kendall Park, NJ 08824

Open in the dashboard

General payments

$0

None reported · program years 2019–2025

Research payments

$560,190

Paid to them · 16 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Gregory Kaufmann of Kendall Park, NJ is reported in the CMS Open Payments database as having received $0 across 0 general payments and $560,190 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 Research $4,850 1
2024 Research $25,425 1
2023 Research $86,950 2
2022 Research $56,450 2
2021 Research $56,850 4
2020 Research $66,200 4
2019 Research $263,465 2

Billing to Medicare

Part B · data year 2024 · 133 billing codes

Paid by Medicare

$207,334

Of which drugs: $2,500

Medicare patients

2,054

Average age 76

Services billed

28,884

1,316 women, 738 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 64%
Ischemic heart disease 34%
Diabetes 31%
Depression 26%
Chronic kidney disease 24%
Osteoporosis 24%
Atrial fibrillation 22%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, gadoterate meglumine, 0.1 ml A9575 Office 132 21,650 $2,046
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 44 4,540 $455

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

16 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record